Can-Fite BioPharma Ltd.
CANF
Price:
$2.84
Market Cap:
$7.40B
Can-Fite BioPharma Ltd., an Israeli clinical-stage biopharmaceutical company, specializes in the creation of small molecule therapeutic products. These treatments target a range of conditions including various cancers, inflammatory liver disorders, and erectile dysfunction. Its primary drug candidate, Piclidenoson, has successfully advanced through Phase III clinical trials for psoriasis and completed Phase II trials for COVID-19. Another promising asset, Namodenoson, is currently undergoing Phase III clinical evaluation for hepatocellular carcinoma (a form of liver cancer) and is in a Phase IIb study for non-alcoholic steatohepatitis (NASH). Furthermore, CF602 is in preclinical development,...[Read more]
Industry
Biotechnology
IPO Date
2012-11-06
Stock Exchange
AMEX
Ticker
CANF
PE Ratio
[-0.26]
ROE
[-141.01%]
Current Ratio
[3.46]
Dividend Yield
[0%]
Enterprise Value
[7.40B]
Dividend History
The Enterprise Value as of June 2026 (TTM) for Can-Fite BioPharma Ltd. (CANF) is 7.40B
According to Can-Fite BioPharma Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.40B. This represents a change of -77.45% compared to the average of 32.79B of the last 4 quarters.
Can-Fite BioPharma Ltd. (CANF) Historical Enterprise Value (quarterly & annually)
How has CANF Enterprise Value performed in the past?
The mean historical Enterprise Value of Can-Fite BioPharma Ltd. over the last ten years is 51.52B. The current 7.40B Enterprise Value has changed 1.34% with respect to the historical average. Over the past ten years (40 quarters), CANF's Enterprise Value was at its highest in in the December 2015 quarter at 122.06B. The Enterprise Value was at its lowest in in the December 2025 quarter at -5457000.00.
Average
51.52B
Median
57.43B
Minimum
10.06M
Maximum
100.58B
Can-Fite BioPharma Ltd. (CANF) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of Can-Fite BioPharma Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 127.59%
Maximum Annual Enterprise Value = 100.58B
Minimum Annual Increase = -99.97%
Minimum Annual Enterprise Value = 10.06M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 10.06M | -99.97% |
| 2024 | 34.04B | 19.48% |
| 2023 | 28.49B | -44.64% |
| 2022 | 51.46B | -20.97% |
| 2021 | 65.12B | 2.71% |
| 2020 | 63.40B | 127.59% |
| 2019 | 27.86B | -61.50% |
| 2018 | 72.36B | 0.62% |
| 2017 | 71.91B | -28.50% |
| 2016 | 100.58B | -0.97% |
Can-Fite BioPharma Ltd. (CANF) Average Enterprise Value
How has CANF Enterprise Value performed in the past?
The current Enterprise Value of Can-Fite BioPharma Ltd. (CANF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
20.85B
5-year avg
35.82B
10-year avg
51.52B
Can-Fite BioPharma Ltd. (CANF) Enterprise Value vs. Peers
How is CANF’s Enterprise Value compared to its peers?
Can-Fite BioPharma Ltd.’s Enterprise Value is greater than Kazia Therapeutics Limited (-36601866.82), greater than CNS Pharmaceuticals, Inc. (91.17K), greater than Clearmind Medicine Inc. (-5840593.00), greater than Soligenix, Inc. (-1266892.00), greater than GRI Bio, Inc. (-10787878.00), greater than Oragenics, Inc. (-3242702.00), greater than Silo Pharma, Inc. (2.10M), greater than Biodexa Pharmaceuticals Plc (-6777328.01), greater than Jaguar Health, Inc. (27.21M), greater than Calidi Biotherapeutics, Inc. (-3842430.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -36601866.82 | $23.13M | |
| 91.17K | $2.81M | |
| -5840593.00 | $3.40M | |
| -1266892.00 | $4.43M | |
| -10787878.00 | $202.12K | |
| -3242702.00 | $2.81M | |
| 2.10M | $6.00M | |
| -6777328.01 | $2.26M | |
| 27.21M | $179.26K | |
| -3842430.00 | $1.13M |
Build a custom stock screener for Can-Fite BioPharma Ltd. (CANF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Can-Fite BioPharma Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Can-Fite BioPharma Ltd. (CANF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Can-Fite BioPharma Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Can-Fite BioPharma Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Can-Fite BioPharma Ltd. (CANF)?
What is the 3-year average Enterprise Value for Can-Fite BioPharma Ltd. (CANF)?
What is the 5-year average Enterprise Value for Can-Fite BioPharma Ltd. (CANF)?
How does the current Enterprise Value for Can-Fite BioPharma Ltd. (CANF) compare to its historical average?